UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
______________________
SCHEDULE 14A
Proxy Statement Pursuant to Section 14(a) of the
Securities Exchange Act of 1934
______________________
|
|
|
|
|
|
|
|
|
|
|
|
Filed by the Registrant
|
x
|
Filed by a Party other than the Registrant
|
o
|
|
|
|
|
|
|
Check the appropriate box:
|
|
o
|
Preliminary Proxy Statement
|
|
o
|
Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))
|
|
o
|
Definitive Proxy Statement
|
|
x
|
Definitive Additional Materials
|
|
o
|
Soliciting Material Pursuant to §240.14a-12
|
10x Genomics, Inc.
(Name of Registrant as Specified In Its Charter)
|
|
|
|
|
|
|
|
|
Payment of Filing Fee (Check the appropriate box):
|
|
x
|
No fee required.
|
|
|
|
|
|
|
o
|
Fee paid previously with preliminary materials.
|
|
|
|
o
|
Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i) and 0-11
|
|
|
|